Franklin Resources’s Minerva Neurosciences NERV Stock Holding History

Franklin Resources’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-150,115	Closed	-$7.23M	–	1718
2020 Q1	$7.23M	Hold	150,115	–	–	﹤0.01%	860
2019 Q4	$8.54M	Hold	150,115	–	–	﹤0.01%	917
2019 Q3	$9.31M	Hold	150,115	–	–	0.01%	897
2019 Q2	$6.76M	Hold	150,115	–	–	﹤0.01%	973
2019 Q1	$9.44M	Hold	150,115	–	–	0.01%	895
2018 Q4	$8.09M	Hold	150,115	–	–	﹤0.01%	908
2018 Q3	$15.1M	Sell	150,115 -12,487	-8%	-$938K	0.01%	846
2018 Q2	$10.7M	Buy	162,602 +8,227	+5%	+$500K	0.01%	909
2018 Q1	$7.72M	Hold	154,375	–	–	﹤0.01%	965
2017 Q4	$7.47M	Buy	154,375 +5,337	+4%	+$265K	﹤0.01%	1000
2017 Q3	$9.06M	Buy	149,038 +4,275	+3%	+$245K	﹤0.01%	970
2017 Q2	$10.2M	Buy	144,763 +40,625	+39%	+$2.63M	0.01%	941
2017 Q1	$6.75M	Hold	104,138	–	–	﹤0.01%	1053
2016 Q4	$9.79M	Sell	104,138 -2,112	-2%	-$216K	0.01%	961
2016 Q3	$12M	Hold	106,250	–	–	0.01%	934
2016 Q2	$8.68M	Buy	+106,250	New	+$6.76M	﹤0.01%	1000

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources's NERV Position: Q2 2020 in Review

Franklin Resources sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 150,115 shares — an estimated $7.23M sold.

Franklin Resources first reported a position in NERV in Q2 2016 and held it in 16 quarters. The position peaked at $15.1M in Q3 2018. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

Franklin Resources reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
Franklin Resources sold 150,115 Minerva Neurosciences shares in Q2 2020, an estimated $7.23M.
Franklin Resources first reported a position in Minerva Neurosciences in Q2 2016 and held it in 16 quarters.
Franklin Resources's Minerva Neurosciences position peaked at $15.1M in Q3 2018.
80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on Franklin Resources's 13F filing for Q2 2020, filed 13 Aug 2020.